Literature DB >> 21357502

Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.

Sachin S Kandlikar1, Gregory D Fink.   

Abstract

Excess sympathetic nervous system activity (SNA) is linked to human essential and experimental hypertension. To test whether sympathetic activation is associated with a model of deoxycorticosterone acetate (DOCA)-salt hypertension featuring two kidneys and a moderate elevation of blood pressure, we measured whole body norepinephrine (NE) spillover as an index of global SNA. Studies were conducted in chronically catheterized male Sprague-Dawley rats drinking water containing 1% NaCl and 0.2% KCl. After a 7-day surgical recovery and a 3-day control period, a DOCA pellet (50 mg/kg) was implanted subcutaneously in one group of rats (DOCA), while the other group underwent sham implantation (Sham). NE spillover was measured on control day 2 and days 7 and 14 after DOCA administration or sham implantation. During the control period, mean arterial pressure (MAP) was similar in Sham and DOCA rats. MAP was significantly increased in the DOCA group compared with the Sham group after DOCA administration (day 14: Sham = 109 ± 5.3, DOCA = 128 ± 3.6 mmHg). However, plasma NE concentration, clearance, and spillover were not different in the two groups at any time. To determine whether selective sympathetic activation to the kidneys contributes to hypertension development, additional studies were performed in renal denervated (RDX) and sham-denervated (Sham-DX) rats. MAP, measured by radiotelemetry, was similar in both groups during the control and DOCA treatment periods. In conclusion, global SNA is not increased during the development of mild DOCA-salt hypertension, and fully intact renal nerves are not essential for hypertension development in this model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357502      PMCID: PMC3094082          DOI: 10.1152/ajpheart.00972.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  58 in total

1.  Renal sympathetic-nerve ablation for uncontrolled hypertension.

Authors:  Markus P Schlaich; Paul A Sobotka; Henry Krum; Elisabeth Lambert; Murray D Esler
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

2.  Increased sympathetic venoconstriction and reactivity to norepinephrine in mesenteric veins in anesthetized DOCA-salt hypertensive rats.

Authors:  Hui Xu; Gregory D Fink; James J Galligan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-23       Impact factor: 4.733

3.  Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism.

Authors:  Andrew C Kontak; Zhongyun Wang; Debbie Arbique; Beverley Adams-Huet; Richard J Auchus; Shawna D Nesbitt; Ronald G Victor; Wanpen Vongpatanasin
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

4.  TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

5.  The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.

Authors:  Murray Esler
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

Review 6.  Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat.

Authors:  John W Osborn; Gregory D Fink
Journal:  Exp Physiol       Date:  2009-08-28       Impact factor: 2.969

Review 7.  Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats.

Authors:  Henok Yemane; Marius Busauskas; Sarah K Burris; Mark M Knuepfer
Journal:  Exp Physiol       Date:  2009-08-21       Impact factor: 2.969

8.  Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Ashok Jadhav; Emina Torlakovic; Joseph Fomusi Ndisang
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-30

Review 9.  Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.

Authors:  Guido Grassi
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  18 in total

Review 1.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

2.  Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.

Authors:  Christopher T Banek; Madeline M Gauthier; Daniel C Baumann; Dusty Van Helden; Ninitha Asirvatham-Jeyaraj; Angela Panoskaltsis-Mortari; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-07       Impact factor: 3.619

Review 3.  Neurogenic and sympathoexcitatory actions of NaCl in hypertension.

Authors:  Sean D Stocker; Kevin D Monahan; Kirsteen N Browning
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

4.  Global- and renal-specific sympathoinhibition in aldosterone hypertension.

Authors:  Thomas E Lohmeier; Boshen Liu; Drew A Hildebrandt; Adam W Cates; Dimitrios Georgakopoulos; Eric D Irwin
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

Review 5.  DOCA-Salt Hypertension: an Update.

Authors:  Tyler Basting; Eric Lazartigues
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

6.  Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

7.  Intracarotid hypertonic sodium chloride differentially modulates sympathetic nerve activity to the heart and kidney.

Authors:  Robert Frithiof; Tao Xing; Michael J McKinley; Clive N May; Rohit Ramchandra
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

8.  Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Pimonrat Ketsawatsomkron; Henry L Keen; Deborah R Davis; Ko-Ting Lu; Madeliene Stump; T Michael De Silva; Aline M Hilzendeger; Justin L Grobe; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

9.  Cerebrospinal Fluid Hypernatremia Elevates Sympathetic Nerve Activity and Blood Pressure via the Rostral Ventrolateral Medulla.

Authors:  Sean D Stocker; Susan M Lang; Sarah S Simmonds; Megan M Wenner; William B Farquhar
Journal:  Hypertension       Date:  2015-09-28       Impact factor: 10.190

10.  Role of cardiac sympathetic nerves in blood pressure regulation.

Authors:  Erica A Wehrwein; Misa Yoshimoto; Pilar Guzman; Amit Shah; David L Kreulen; John W Osborn
Journal:  Auton Neurosci       Date:  2014-03-01       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.